Literature DB >> 17072194

[Nicorandil-associated anal ulceration].

A-L Rival1, C Allombert-Blaise, A Ly, J-P Grandjean, M Faure, A Claudy.   

Abstract

BACKGROUND: Nicorandil is a potassium-channel activator used in the treatment of angina pectoris. The first cases of anal ulcerations induced by nicorandil were published in 2002. CASE REPORT: A 71-year-old man presented with a 2-year history of anal ulcerations occurring within a few months of initiation of treatment with Nicorandil. Histological tests on a biopsy sample showed granulation tissue with non-specific chronic inflammation. Nicorandil was stopped and this resulted in complete healing of the ulcers after three months. DISCUSSION: Nicorandil can induce chronic and extensive anal ulcerations. The pathogenesis is unknown. Patients are usually treated with high doses of nicorandil. Dermatologists should be aware of this rare side-effect which heals after withdrawal of the drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072194     DOI: 10.1016/s0151-9638(06)71043-2

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  2 in total

Review 1.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

Review 2.  Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance network.

Authors:  Valérie Babic; Nadine Petitpain; Claire Guy; Philippe Trechot; Anne Claire Bursztejn; Jean Luc Faillie; Thierry Vial; Jean Luc Schmutz; Pierre Gillet
Journal:  Int Wound J       Date:  2018-05-16       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.